New liquid form of maribavir tested in healthy adults

NCT ID NCT04131556

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This early-stage study tested two liquid versions of the drug maribavir (used to treat certain viral infections) to see how well they are absorbed, how they taste, and if they are safe compared to the current tablet. The study involved 20 healthy adults, not children, to gather initial data. The goal is to eventually develop a child-friendly formulation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

maribavir

What this could lead to

If successful, this could lead to a child-friendly liquid version of maribavir, making it easier to give to children who need it.

What could go wrong

This is a very early (Phase 1) study in only 20 healthy adults, not children. The liquid formulations may not work as well or taste acceptable, and the study was terminated early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinical Pharmacology of Miami, Llc

    Miami, Florida, 33014, United States